Nosiheptide

  • CAT Number: R017657
  • CAS Number: 56377-79-8
  • Molecular Formula: C51H43N13O12S6
  • Molecular Weight: 1222.4
  • Purity: ≥95%
Inquiry Now

A bicyclic thiopeptide antibiotic produced by several species of actinomycetes, notably streptomyces; has broad spectrum antibacterial activity; demonstrated a prolonged post-antibiotic effect in both nosocomial and community-acquired MRSA compared with vancomycin

Catalog Number R017657
CAS Number 56377-79-8
Molecular Formula

C51H43N13O12S6

Purity 95%
Storage -20°C
InChIKey OQAOHXRUMXWDLQ-OIHXUFRMSA-N
SMILES OC1=C(C2=NC(C(NC(C(N)=O)=C)=O)=CS2)N=C(C3=CSC([C@](NC(C4=CSC([C@](NC(C5=CSC(/C(NC([C@](NC(C6=CSC7=N6)=O)([H])[C@@H](O)C)=O)=C/C)=N5)=O)([H])C[C@H](O)C(OC8)=O)=N4)=O)([H])CSC(C9=C(C)C(C8=CC=C%10)=C%10N9)=O)=N3)C7=C1
Reference

A new antibiotic, multhiomycin. Tanaka T. et al. J. Antibiot. 1970, 23, 231.<br />
<br />
Identity of multhiomycin with nosiheptide. Endo T. and Yonehara H. J. Antibiot, 1978, 31, 623.<br />
<br />
Thiostrepton group of antibiotics. Pestka S. and Bodley J. Antibiotics. III. 1975, 551-573 ed. Corcoran J.W. &amp; Harn F.E., Springer-Verlag, New York.<br />
<br />
Activity of the thiopeptide antibiotic, nosiheptide, against contemporary strains of methicillin-resistant Staphylococcus aureus. Haste N.M. et al. J. Antibiot. 2012, 65, 593.
<p>
<br />
</p>

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!